Literature DB >> 28956767

The Exonuclease Activity of Herpes Simplex Virus 1 UL12 Is Required for Production of Viral DNA That Can Be Packaged To Produce Infectious Virus.

Lorry M Grady1, Renata Szczepaniak1, Ryan P Murelli2,3, Takeshi Masaoka4, Stuart F J Le Grice4, Dennis L Wright5, Sandra K Weller6.   

Abstract

The herpes simplex virus (HSV) type I alkaline nuclease, UL12, has 5'-to-3' exonuclease activity and shares homology with nucleases from other members of the Herpesviridae family. We previously reported that a UL12-null virus exhibits a severe defect in viral growth. To determine whether the growth defect was a result of loss of nuclease activity or another function of UL12, we introduced an exonuclease-inactivating mutation into the viral genome. The recombinant virus, UL12 D340E (the D340E mutant), behaved identically to the null virus (AN-1) in virus yield experiments, exhibiting a 4-log decrease in the production of infectious virus. Furthermore, both viruses were severely defective in cell-to-cell spread and produced fewer DNA-containing capsids and more empty capsids than wild-type virus. In addition, DNA packaged by the viral mutants was aberrant, as determined by infectivity assays and pulsed-field gel electrophoresis. We conclude that UL12 exonuclease activity is essential for the production of viral DNA that can be packaged to produce infectious virus. This conclusion was bolstered by experiments showing that a series of natural and synthetic α-hydroxytropolones recently reported to inhibit HSV replication also inhibit the nuclease activity of UL12. Taken together, our results demonstrate that the exonuclease activity of UL12 is essential for the production of infectious virus and may be considered a target for development of antiviral agents.IMPORTANCE Herpes simplex virus is a major pathogen, and although nucleoside analogs such as acyclovir are highly effective in controlling HSV-1 or -2 infections in immunocompetent individuals, their use in immunocompromised patients is complicated by the development of resistance. Identification of additional proteins essential for viral replication is necessary to develop improved therapies. In this communication, we confirm that the exonuclease activity of UL12 is essential for viral replication through the analysis of a nuclease-deficient viral mutant. We demonstrate that the exonuclease activity of UL12 is essential for the production of viral progeny and thus provides an attractive, druggable enzymatic target.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  DNA recombination; DNA replication; HSV; UL12; drug discovery; exonucleases; viral DNA

Mesh:

Substances:

Year:  2017        PMID: 28956767      PMCID: PMC5686714          DOI: 10.1128/JVI.01380-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  83 in total

1.  Grouping together highly diverged PD-(D/E)XK nucleases and identification of novel superfamily members using structure-guided alignment of sequence profiles.

Authors:  J M Bujnicki; L Rychlewski
Journal:  J Mol Microbiol Biotechnol       Date:  2001-01

2.  Biochemical studies of the maturation of herpesvirus nucleocapsid species.

Authors:  M L Perdue; J C Cohen; C C Randall; D J O'Callaghan
Journal:  Virology       Date:  1976-10-01       Impact factor: 3.616

3.  The exonuclease activity of HSV-1 UL12 is required for in vivo function.

Authors:  J N Goldstein; S K Weller
Journal:  Virology       Date:  1998-05-10       Impact factor: 3.616

4.  Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro.

Authors:  L Yang; M S Wold; J J Li; T J Kelly; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  The herpes simplex virus type 1 alkaline nuclease is not essential for viral DNA synthesis: isolation and characterization of a lacZ insertion mutant.

Authors:  S K Weller; M R Seghatoleslami; L Shao; D Rowse; E P Carmichael
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

Review 6.  Causes and consequences of replication stress.

Authors:  Michelle K Zeman; Karlene A Cimprich
Journal:  Nat Cell Biol       Date:  2014-01       Impact factor: 28.824

7.  Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase.

Authors:  J Parkinson; S P Lees-Miller; R D Everett
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  HSV-I and the cellular DNA damage response.

Authors:  Samantha Smith; Sandra K Weller
Journal:  Future Virol       Date:  2015-04       Impact factor: 1.831

9.  Rad51 protein controls Rad52-mediated DNA annealing.

Authors:  Yun Wu; Noriko Kantake; Tomohiko Sugiyama; Stephen C Kowalczykowski
Journal:  J Biol Chem       Date:  2008-03-12       Impact factor: 5.157

10.  The herpesvirus alkaline exonuclease belongs to the restriction endonuclease PD-(D/E)XK superfamily: insight from molecular modeling and phylogenetic analysis.

Authors:  J M Bujnicki; L Rychlewski
Journal:  Virus Genes       Date:  2001-03       Impact factor: 2.198

View more
  15 in total

1.  Distinguishing Features of High- and Low-Dose Vaccine against Ocular HSV-1 Infection Correlates with Recognition of Specific HSV-1-Encoded Proteins.

Authors:  Daniel J J Carr; Grzegorz B Gmyrek; Adrian Filiberti; Amanda N Berube; William P Browne; Brett M Gudgel; Virginie H Sjoelund
Journal:  Immunohorizons       Date:  2020-10-09

2.  Importance of lipophilicity for potent anti-herpes simplex virus-1 activity of α-hydroxytropolones.

Authors:  Alex J Berkowitz; Abaigeal D Franson; Andreu Gazquez Cassals; Katherine A Donald; Alice J Yu; Aswin K Garimallaprabhakaran; Lynda A Morrison; Ryan P Murelli
Journal:  Medchemcomm       Date:  2019-05-30       Impact factor: 3.597

3.  The DNase Activity of Kaposi's Sarcoma-Associated Herpesvirus SOX Protein Serves an Important Role in Viral Genome Processing during Lytic Replication.

Authors:  Timsy Uppal; Dylan Meyer; Andrea Agarwal; Subhash C Verma
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

4.  Host translesion polymerases are required for viral genome integrity.

Authors:  Sebastian Zeltzer; Pierce Longmire; Marek Svoboda; Giovanni Bosco; Felicia Goodrum
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-10       Impact factor: 12.779

5.  Synthesis of Polyoxygenated Tropolones and their Antiviral Activity against Hepatitis B Virus and Herpes Simplex Virus-1.

Authors:  Daniel V Schiavone; Diana M Kapkayeva; Qilan Li; Molly E Woodson; Andreu Gazquez Casals; Lynda A Morrison; John E Tavis; Ryan P Murelli
Journal:  Chemistry       Date:  2022-01-31       Impact factor: 5.236

6.  Herpes simplex virus 1 ICP8 mutant lacking annealing activity is deficient for viral DNA replication.

Authors:  Savithri Weerasooriya; Katherine A DiScipio; Anthar S Darwish; Ping Bai; Sandra K Weller
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-31       Impact factor: 11.205

7.  Four-dimensional analyses show that replication compartments are clonal factories in which Epstein-Barr viral DNA amplification is coordinated.

Authors:  Thejaswi Nagaraju; Arthur U Sugden; Bill Sugden
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-19       Impact factor: 11.205

8.  Divergent synthesis of a thiolate-based α-hydroxytropolone library with a dynamic bioactivity profile.

Authors:  Nana B Agyemang; Cassandra R Kukla; Tiffany C Edwards; Qilan Li; Madison K Langen; Alexandra Schaal; Abaigeal D Franson; Andreu Gazquez Casals; Katherine A Donald; Alice J Yu; Maureen J Donlin; Lynda A Morrison; John E Tavis; Ryan P Murelli
Journal:  RSC Adv       Date:  2019-10-23       Impact factor: 4.036

Review 9.  Mitochondrial DNA in inflammation and immunity.

Authors:  Joel S Riley; Stephen Wg Tait
Journal:  EMBO Rep       Date:  2020-03-23       Impact factor: 8.807

Review 10.  The three-component helicase/primase complex of herpes simplex virus-1.

Authors:  Oya Bermek; R Scott Williams
Journal:  Open Biol       Date:  2021-06-09       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.